Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.669, 2013-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
QOL benefits with palliative chemotherapy in ovarian cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 307, 2001-01 ,pp. :
Access to resources
Recommend
Switch to anastrozole benefits QOL in breast cancer
Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. :
Switch from tamoxifen to anastrozole benefits QOL in breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 520, 2007-01 ,pp. :
. . . and also shows QOL benefits
Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. :
Ranolazine provides sustained improvements in health status and QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 551, 2008-01 ,pp. :